Ulrike Lorch
- The safety, tolerability and pharmacokinetics of AZD5069, a novel CXCR2 antagonist, in healthy Japanese volunteersBy Ulrike Lorch, Hedigo Negi, Hirobumi Tabata, Heather Wray, Marie Cullberg and Bengt LarssonUlrike Lorch1Richmond Pharmacology, St. George's University, London, United KingdomHedigo Negi2Research & Development, AstraZeneca K.K., Osaka, JapanHirobumi Tabata2Research & Development, AstraZeneca K.K., Osaka, JapanHeather Wray3Research & Development, AstraZeneca, Mölndal, SwedenMarie Cullberg3Research & Development, AstraZeneca, Mölndal, SwedenBengt Larsson3Research & Development, AstraZeneca, Mölndal, Sweden
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.